This episode digs into a striking case study linking perimenopause to neuroinflammation and late-onset mania — and asks why psychiatry so rarely looks at hormonal transitions when a woman presents with new-onset psychiatric symptoms. We also get into the emerging science of how estrogen loss affects blood pressure regulation, and flag a new retrospective study on a rare but aggressive breast cancer subtype.

Key Takeaways:

• A 2026 case study proposes that perimenopause-driven neuroinflammation may be a trigger for late-onset mania in women with no prior psychiatric history — and that clinicians systematically miss this connection.

• Estrogen appears to interact with stretch-sensing receptors in the aorta (baroreceptors) that help regulate blood pressure, which may help explain why cardiovascular risk rises after menopause.

• Infiltrating micropapillary carcinoma (IMPC) is a rare, aggressive breast cancer subtype — the 2026 retrospective study highlights it tends to present at higher grade and with higher rates of lymph node involvement than more common subtypes.

• The average physician receives roughly one hour of menopause-specific training in medical school, which has real consequences when a woman presents with what looks like a psychiatric emergency.

• Blood pressure changes in perimenopause and menopause are not purely about weight or stress — the hormonal mechanism is more direct than most clinical conversations acknowledge.

Sources & References:

• From perimenopause to neuroinflammation: Rethinking a case of late-onset mania (https://pubmed.ncbi.nlm.nih.gov/42359388/) - PubMed

• Estradiol, baroreceptors, and baroreflex sensitivity in hypertension (https://pubmed.ncbi.nlm.nih.gov/42359345/) - PubMed

• Risk factors and prognosis in infiltrating micropapillary breast carcinoma: a retrospective study (https://pubmed.ncbi.nlm.nih.gov/42359336/) - PubMed

Listen with full show notes: https://hotflasher.com/episodes/2026-06-26-listener-story

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode covers three things making noise this week: a 24-year-old breast cancer survivor going through medically-induced menopause alongside her mother, a new NAMS journal piece on nocturia and why postmenopausal women keep waking up to use the bathroom, and a USA Today breakdown of menopause legislation currently moving through the US policy conversation. Lenses: medical-system frustration and research credibility.

Key Takeaways:

• Medically-induced menopause from cancer treatment can happen at any age — chemotherapy and surgery can shut down ovarian function in women in their teens and twenties, creating the same hormonal landscape as natural menopause but with fewer clinical resources designed for that age group.

• Nocturia (waking at night to urinate) is one of the most common and most disruptive postmenopausal symptoms, and it's not just a bladder problem — declining estrogen affects urethral tissue, bladder capacity, and sleep architecture all at once, per the NAMS journal.

• The term "nocturia" means waking one or more times per night specifically to urinate — distinct from general sleep disruption, and worth naming precisely when talking to a doctor.

• Several pieces of US menopause legislation are in progress, targeting areas like insurance coverage for HRT, provider training requirements, and research funding — none signed into law yet as of June 2026.

• The average physician receives approximately one hour of menopause-specific training in medical school, which is part of the policy argument driving the legislative push.

Sources & References:

• She got breast cancer at 19. At 24, she's going through menopause at the same time as her mom. (https://news.google.com/rss/articles/CBMiqwFBVV95cUxQOUMzRTZNeXNaeXY3U25iR053aE5XV1FQS3hhWm1JOWpkYXRjVVh1QXF1cXpvejdLMGVJX2hDVk5neEl3aWZHQWFxNGN5SUxuM1Nrd3VLSlpIbm5oMTZaVENDdmRtdEhlMEd2WHYxR2ZiZGJKVWNHeWNrZmlXb2RZc2lqa0dmRWxWUktkLWFURGo2U3N0UGFiUnFwSTNfS01QVHpVN3N5TVNQckE?oc=5) - Business Insider

• Nocturia in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42329106/) - Menopause (NAMS Journal)

• There's 'menopause legislation' in the works. What does that mean? (https://news.google.com/rss/articles/CBMiqgFBVV95cUxONWlyNWsxXzhadkw1M0ZHRGFHV2xFSGhCbzlqRlRqTkVFU01fOVpmVGJJcnFKeVM1czdsSFIwdzQ5c3FnWm9UNFpSSG5TdnNXNVVLNXZBaTk5c1Y2ZUFEeWFnaTN2Ty1hZm5sWmkyNElZcmVnUTkzRHByb253d0J6dndXTWdrNWFhZG92QWFMWVRjOFE4eGFhcmp2aXpQQk5HV1hzaXZqUGpkQQ?oc=5) - USA Today

Listen with full show notes: https://hotflasher.com/episodes/2026-06-25-influencer-roundup

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

Three items worth knowing about today: a devastating misdiagnosis story that exposes what happens when "menopause and anxiety" becomes a catch-all explanation for women's symptoms, new clinical guidance on why postmenopausal women wake up to use the bathroom multiple times a night, and a study on a dietary change that may help with cholesterol after menopause. Practical, a little sobering, and worth your 10 minutes.

Key Takeaways:

• Cognitive and behavioral changes in midlife women can have causes unrelated to menopause — including serious neurological conditions — and dismissing them as "just menopause or anxiety" without investigation carries real risk.

• Nocturia (waking at night to urinate) affects a significant portion of postmenopausal women and is driven by hormonal, anatomical, and physiological changes specific to menopause — not simply aging or light sleep.

• Nocturia has downstream effects on sleep quality, mood, and cardiovascular health, and is undertreated partly because women don't bring it up and clinicians don't ask.

• A recent study covered by EatingWell points to a specific dietary drink as potentially helpful for post-menopause cholesterol — but the finding comes from a small or observational study, and the headline is doing more work than the data warrants.

• Post-menopause cardiovascular risk is real and underappreciated; estrogen's departure changes the lipid profile in ways that deserve active monitoring, not passive waiting.

Sources & References:

• Mom's confusion dismissed as menopause and anxiety — then diagnosed with incurable brain cancer (https://news.google.com/rss/articles/CBMijAFBVV95cUxNQ3o4dVhJbTdzN20tdU1MekdVckYxY0JNOFlDcEtYNTJxZThmcTZIXzFPaXl1RFpPdEM4elRKQXNBclVRakwxWGY0bmJCTjNzc1c3bVpKTzZvYXBEZ1UyNDVTM3BoNG9LWndlanl6RENTZ1JtRlhyR1ZSN3hwY2JfUko0VFhLeXlfWEp3Ng?oc=5) - People.com

• Nocturia in postmenopausal women — Practice Pearl (https://pubmed.ncbi.nlm.nih.gov/42329106/) - Menopause (NAMS Journal)

• This drink could help lower your cholesterol after menopause, new study says (https://news.google.com/rss/articles/CBMidkFVX3lxTE1SMHRKTkc5Nm43Qm1lM0s0R1ZBVnlrTjdOY2lURVNoaTUxb1JSWjJIN25MR2k2OGJjUmY0bV9JczRVZVdaTG5URllXQmlTNEUwdThKMnVNcEVHOUJVUXlBTzFrWjFsQlRxZHBqb2ItSG9CLURKaWc?oc=5) - EatingWell

Listen with full show notes: https://hotflasher.com/episodes/2026-06-24-myth-busting

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode goes deep on three menopause symptoms that rarely get named, let alone explained: nocturia (nighttime urination), coronary microvascular dysfunction, and the estrogen-histamine connection behind mystery allergic reactions and anxiety. Each one has a real hormonal mechanism — and each one gets missed or misattributed more often than it should.

Key Takeaways:

• Nocturia — waking one or more times per night to urinate — is common in postmenopausal women and driven by multiple hormonal and anatomical changes, not just fluid intake or aging.

• Coronary microvascular dysfunction causes chest pain and exercise intolerance in midlife women and is frequently missed because standard cardiac testing often comes back normal.

• Estrogen fluctuations in perimenopause can destabilize mast cells, increasing histamine release — which can look like sudden-onset allergies, flushing, anxiety, and itching.

• All three conditions are underrepresented in general medical training, which means women are often dismissed or misdiagnosed before anyone connects the dots to hormonal changes.

• If you're experiencing any of these symptoms and getting nowhere with a general practitioner, that's not a sign the symptoms aren't real — it's a sign you may need a specialist who works in this space.

Sources & References:

• Nocturia in postmenopausal women — Practice Pearl (https://pubmed.ncbi.nlm.nih.gov/42329106/) - Menopause (NAMS Journal)

• Coronary microvascular dysfunction in menopausal women (https://pubmed.ncbi.nlm.nih.gov/42331611/) - PubMed

Listen with full show notes: https://hotflasher.com/episodes/2026-06-23-symptom-spotlight

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode covers three developments at the intersection of menopause and brain health, cardiovascular risk, and workplace policy. A new NAMS journal study finds statins may be adding to the cognitive and symptom burden postmenopausal women already carry — and that the overlap is almost certainly being misread. A separate study shows that APOE4 carriers may not get the same brain-protective benefits from estrogen that other women do, which matters enormously for how we think about HRT and Alzheimer's risk. And Washington State's governor just signed an Executive Order making menopause support in the workplace official policy.

Key Takeaways:

• A study in the NAMS journal found statin use in postmenopausal women was linked to poorer delayed recall memory, worse visuospatial function, higher menopause symptom burden, and elevated sarcopenia risk — effects that can easily be misattributed to menopause alone.

• Statins were not associated with mild cognitive impairment in this study, which is an important distinction — but the subtler cognitive and physical effects are still clinically meaningful and worth flagging with your doctor.

• A 2026 study found that the APOE4 genotype negates the protective effects of ovarian hormones on cerebrovascular endothelial and mitochondrial function — meaning estrogen's brain benefits may not apply equally to women who carry this Alzheimer's risk gene.

• Washington Governor Bob Ferguson signed an Executive Order directing state agencies to support employees experiencing perimenopause and menopause in the workplace — one of the more concrete government actions on this issue in the US to date.

• Both brain-health studies point toward the need for more individualized care: knowing your APOE4 status and your medication profile matters more than most standard menopause appointments currently account for.

Sources & References:

• Statin use linked to poorer memory, visuospatial function, and higher menopause symptom burden in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42299882/) - Menopause (NAMS Journal)

• APOE4 genotype negates the protective effects of ovarian hormones on cerebrovascular and mitochondrial function (https://pubmed.ncbi.nlm.nih.gov/42321014/) - PubMed

• Governor Ferguson signs Executive Order supporting women experiencing perimenopause and menopause in the workplace (https://governor.wa.gov) - Governor Bob Ferguson (.gov)

Listen with full show notes: https://hotflasher.com/episodes/2026-06-22-research-roundup

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

Dr. Hillary McBride's work on embodiment reframes menopause as a psychological and cultural turning point, not just a hormonal one. A new cross-sectional study links cardiorespiratory fitness to fewer menopause symptoms and a better cardiometabolic profile. And a secondary analysis of the Women's Health Initiative finds that a low-fat dietary pattern did not reduce dementia mortality in postmenopausal women.

Key Takeaways:

• Dr. Hillary McBride's research suggests the cultural stories women absorb about aging can shape the physical and psychological experience of menopause itself.

• A cross-sectional study published in the NAMS journal found cardiorespiratory fitness was independently associated with a more favorable cardiometabolic risk profile and fewer menopause-related symptoms in midlife women.

• The same study did not find a significant association between cardiorespiratory fitness and vascular function, suggesting other factors drive vascular health during the transition.

• A secondary analysis of the Women's Health Initiative randomized trial found that a low-fat eating pattern did not reduce dementia mortality in postmenopausal women over long-term follow-up.

• The dementia finding challenges a common dietary assumption and underscores why menopause-specific nutrition research matters more than generic population-level dietary guidelines.

Sources & References:

• Menopause Is a Portal: Reclaiming the Body, the Story, and the Second Half with Dr. Hillary McBride (https://www.maryClairehavermd.com/unpause-podcast) - unPAUSED with Dr. Mary Claire Haver

• Cardiorespiratory fitness, cardiovascular disease risk factors, and quality of life in perimenopausal and postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42299904/) - Menopause (NAMS Journal)

• Low-fat dietary pattern and dementia mortality: secondary analysis of the Women's Health Initiative (https://pubmed.ncbi.nlm.nih.gov/42262514/) - Menopause (NAMS Journal)

Listen with full show notes: https://hotflasher.com/episodes/2026-06-19-listener-story

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode covers a 2026 study on how the APOE4 gene variant disrupts the brain's energy metabolism during menopause, Shania Twain's candid comments about body image after menopause, and a small pilot study on a negative pressure device for genitourinary syndrome of menopause. Three genuinely different topics, all worth knowing about this week.

Key Takeaways:

• Women who carry the APOE4 gene variant may experience a more pronounced disruption in how brain cells switch fuel sources during the menopause transition — a shift that some researchers connect to elevated Alzheimer's risk in this population.

• The brain's preferred fuel source shifts from glucose to ketone-based metabolism during menopause; APOE4 appears to interfere with that adaptive process, according to a 2026 study by Wang et al.

• Shania Twain publicly described menopause as having improved her relationship with her body — a notable counternarrative to the predominantly negative media framing of this life stage.

• A small feasibility pilot (NAMS Journal, 2026) found that a negative pressure device called the VITA AV system was tolerated by women with GSM, with no safety issues and self-reported symptom improvements — but the sample was small and controlled trials haven't been done yet.

• GSM (genitourinary syndrome of menopause) affects an estimated 50–70% of postmenopausal women but remains significantly under-discussed and undertreated; the treatment pipeline beyond topical estrogen is genuinely expanding.

Sources & References:

• APOE4 accelerates menopause-associated brain metabolic shift and disrupts bioenergetic adaptation (https://pubmed.ncbi.nlm.nih.gov/42311497/) - PubMed

• Shania Twain says menopause improved her body image (https://news.google.com/rss/articles/CBMiTEFVX3lxTE50bnZHZTRUcElGSW5QeGhOLXhiQjBpeDJfeGlHV2lrd0VYU2RaWXUzbUNXUUZFZGxZYXFfVHRLRFNONWt6YlBzRkYwZV8?oc=5) - ABC News

• Novel negative pressure treatment for genitourinary syndrome of menopause: feasibility pilot study with the VITA AV system (https://pubmed.ncbi.nlm.nih.gov/42299902/) - Menopause (NAMS Journal)

Listen with full show notes: https://hotflasher.com/episodes/2026-06-18-influencer-roundup

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode covers three studies from the NAMS journal, all landing in the same week with myth-busting implications. Perimenopausal sleep disruption may have lasting effects on cognitive function; statins carry memory-related effects worth knowing about even as they protect the heart; and a novel non-hormonal device for genitourinary syndrome of menopause is showing early promise for women who thought vaginal symptoms were just something to live with.

Key Takeaways:

• Women frequently woken by menopausal symptoms during perimenopause showed measurably poorer cognitive function decades later, suggesting sleep disruption in midlife is a marker worth taking seriously — not just waiting out.

• Statin therapy in postmenopausal women was not linked to mild cognitive impairment overall, but was associated with poorer delayed recall memory and visuospatial function, as well as higher menopausal symptom burden and sarcopenia risk.

• The cognitive and somatic effects of statins can overlap with menopausal symptoms, which matters when doctors are trying to sort out what's causing what in a postmenopausal patient.

• A small feasibility pilot study of a negative pressure device for genitourinary syndrome of menopause (GSM) found it was well-tolerated with no safety issues and reported symptom improvements — larger controlled trials are needed before drawing firm conclusions.

• GSM affects a significant portion of postmenopausal women and remains undertreated; non-hormonal options with emerging evidence are worth tracking for women who can't or don't want to use hormonal therapies.

Sources & References:

• Perimenopausal sleep disturbances linked to poorer cognitive function decades later (https://pubmed.ncbi.nlm.nih.gov/42302113/) - Menopause (NAMS Journal)

• Statin use in postmenopausal women associated with poorer memory and higher menopausal symptom burden (https://pubmed.ncbi.nlm.nih.gov/42299882/) - Menopause (NAMS Journal)

• Negative pressure device shows feasibility for treating genitourinary syndrome of menopause (https://pubmed.ncbi.nlm.nih.gov/42299902/) - Menopause (NAMS Journal)

Listen with full show notes: https://hotflasher.com/episodes/2026-06-17-myth-busting

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

The New York Times framed this weekend's piece as women being 'left out' of hormone therapy. We take a closer look at one of the three women profiled and argue that at least one of these stories isn't a contraindication — it's a provider-knowledge gap. The Menopause Society's own 2022 position on transdermal estrogen and clot risk has been clear for years; the question is whether your doctor has read it.

Key Takeaways:

• The Menopause Society's 2022 Hormone Therapy Position Statement says transdermal routes and lower doses may decrease the risk of VTE compared to oral estrogen

• Dr. Stephanie Faubion, quoted in the same NYT piece, is the medical director of The Menopause Society — and has been publishing on the route-of-administration distinction for years

• Dr. Rajita Patil at UCLA called the provider-knowledge gap 'humongous'; many clinicians are still not up to speed on transdermal estrogen, micronized progesterone, or testosterone

• If you have been told you can't take HRT, three things to ask: was the 'no' about oral or transdermal estrogen, has your provider read the Menopause Society's 2022 position statement, and can they refer you to a menopause-certified clinician if they cannot answer

Sources & References:

• Millions of Women Can't Take Hormone Therapy. Here's What They Want You to Know (NYT, 2026-06-15) (https://www.nytimes.com/2026/06/15/well/menopause-hormone-therapy-breast-cancer.html)

• The Menopause Society — 2022 Hormone Therapy Position Statement (https://menopause.org/wp-content/uploads/professional/nams-2022-hormone-therapy-position-statement.pdf)

• Find a Menopause Society Certified Practitioner (https://menopause.org/patient-education/find-a-menopause-practitioner)

Listen with full show notes: https://hotflasher.com/episodes/2026-06-16-hrt-provider-gap-special

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

Three new studies reveal surprising aspects of menopause: a promising botanical treatment for hot flashes with solid clinical trial backing, research connecting childhood trauma to worse menopausal symptoms, and fascinating findings on how estrogen loss affects women's bodies even in extreme environments like high-altitude Nepal.

Key Takeaways:

• A new botanical compound targeting neurokinin pathways showed significant reduction in hot flash frequency in a randomized controlled trial

• Women with adverse childhood experiences report more severe menopausal symptoms and worse quality of life during the transition

• Post-menopausal Tibetan women at high altitude show altered cardiovascular responses to low oxygen, suggesting estrogen's protective effects extend to extreme environments

• Trauma-informed care during menopause could help healthcare providers better support women with severe symptoms

Sources & References:

• Adverse childhood experiences linked to worse menopause symptoms and quality of life (https://pubmed.ncbi.nlm.nih.gov/42262438/) - Menopause (NAMS Journal)

Listen with full show notes: https://hotflasher.com/episodes/2026-06-15-research-roundup

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.